Northway Biotech
24.5.2023 18:24:40 CEST | ACCESS Newswire | Press release
WALTHAM, MA / ACCESSWIRE / May 24, 2023 / Northway Biotech, a biopharmaceutical contract development and manufacturing organization (CDMO), established in 2004, with an EMA and FDA-compliant, state-of-the-art cGMP manufacturing site in Vilnius, Lithuania, announced the completion of its expansion project for cGMP manufacturing facilities in Waltham, Massachusetts. This significant accomplishment further solidifies Northway Biotech's standing as an influential player in the global biopharmaceutical landscape.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.This recent growth is an extension of the successful launch of Northway Biotech's process and analytical development laboratories in Waltham (Greater Boston area) in 2020. The expanded facility now includes state-of-the-art cGMP suites, marking a significant milestone in the company's journey. The newly established cutting-edge biomanufacturing suites host a microbial fermentation train with up to 450 liters of volume capacity, and a mammalian production train with the ability to handle volumes of up to 2,000 liters. Northway Biotech has further established a specialized, fully automated fill and finish line to accommodate its clients' varied needs, supporting high-throughput filling into vials, syringes, and cartridges.
Prof. Vladas Algirdas Bumelis, CEO of Northway Biotech, shared his insights regarding this accomplishment, stating, "The addition of GMP suites in our US site represents a transformative step for our organization, enabling us to provide comprehensive end-to-end solutions from our second site now. We are poised to transition current process development projects into the cGMP manufacturing phase in a timely manner, in line with our clients' committed schedules. Additionally, our longstanding US partners who have engaged with our Lithuanian site can now also take advantage of the geographical convenience of our modern facilities located in the Greater Boston Area. With our fully functional and technologically advanced manufacturing site at our disposal, Northway Biotech is perfectly positioned to take on manufacturing projects aimed at both clinical and commercial supply."
To commemorate this significant expansion and express gratitude to its valued partners and industry leaders, Northway Biotech will be hosting a grand opening event for its cGMP suites on June 8. This event promises to be an occasion of celebration and networking, providing an opportunity for attendees to witness firsthand the state-of-the-art facilities and engage in meaningful discussions within the biotech community.
About Northway Biotech - https://www.northwaybiotech.com
Northway Biotech is a leading contract development and manufacturing organization (CDMO) supporting customers worldwide. Its highly experienced, professional team executes projects at any stage, from cell line construction and process development to cGMP manufacturing of biopharmaceutical products. The company's wide-ranging expertise and vertically integrated service offering translate to the ability to rapidly execute multiple projects from its state-of-the-art GMP facilities while ensuring full process and product compliance at all stages of research, development and commercial manufacturing. Northway Biotech is a privately-owned company founded in 2004 and located in Vilnius, Lithuania; London, United Kingdom; and Waltham, Massachusetts, United States.
For Further Information, Contact:
Prof. Vladas Algirdas Bumelis
CEO and Chairman of the Board
Northway Biotech
vladas.bumelis@northwaybiotech.com
Contact Information
Vladas Bumelis
CEO and Chairman of the Board
vladas.bumelis@northwaybiotech.com
SOURCE: Northway Biotech
To view this piece of content from stats.newswire.com, please give your consent at the top of this page.View source version on accesswire.com:
https://www.accesswire.com/757061/Northway-Biotech-Set-to-Launch-Advanced-Microbial-and-Mammalian-GMP-Facilities-in-Massachusetts
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Leggett Dynamics Launches Mid-Class Massage System & Makes Luxury Comfort Accessible on High-Volume Programs22.6.2026 13:00:00 CEST | Press release
DETROIT, MI / ACCESS Newswire / June 22, 2026 / Leggett Dynamics today launched its Mid-Class Massage System (MCM), a breakthrough non-electronic innovation that makes premium massage more accessible beyond the luxury vehicle segment. Now in production with a global OEM, MCM was also shortlisted for the 2026 Auto Tech Partnership Award for industry-leading innovation and collaboration. Breakthrough by Design MCM creates a distinctive massage experience with a compact 30 x 35 mm module that uses the Coandă effect, an air jet's natural tendency to follow a curved surface. With no electronics or moving parts, it reduces complexity and cost, making a premium experience accessible to more vehicle segments and consumers. Balancing Innovation, Speed and Cost "Automakers must balance innovation, speed and cost while consumers expect more personalized, affordable, premium experiences," said Julien Rea, VP of Global Innovation & Engineering at Leggett Dynamics. "Leggett Dynamics' Mid-Class Massa
EcoModular Advances EIC STEP Scale Up Application to Support European Manufacturing Expansion22.6.2026 09:55:00 CEST | Press release
AI-native robotics platform engages European innovation-funding specialist Catalyze to prepare its submission to the European Innovation Council's STEP Scale-Up programme, with its EU Manufacturing Hub as the anchor of a planned European scale-up DUBLIN, IE / ACCESS Newswire / June 22, 2026 / EcoModular, the AI-native robotics platform for volumetric manufacturing operated by Ascotway Limited and advancing a Nasdaq Capital Market direct listing, today announced that it has engaged Catalyze B.V., a leading European innovation-funding consultancy, to prepare and submit an application to the European Innovation Council (EIC) STEP Scale-Up programme. The application is being prepared for the programme's evaluation batch dated 9 September 2026. The EIC STEP Scale-Up programme forms part of the European Union's Strategic Technologies for Europe Platform (STEP) and is administered by the European Innovation Council. It is designed to provide investment support to European companies scaling st
Bear Robotics to Acquire Kinisi Robotics, Completing Its End-to-End Physical AI Robotics Platform22.6.2026 09:00:00 CEST | Press release
Kinisi adds the manipulation AI layer that completes Bear's multi-robot Physical AI platform - extending Bear's deployed fleet from moving and delivering to handling physical work itself. REDWOOD CITY, CA / ACCESS Newswire / June 22, 2026 / Bear Robotics today announced it has signed a definitive agreement to acquire Kinisi Robotics, in a transaction that will make Kinisi part of Bear. On closing, Kinisi's KR1 humanoid robot, its Bristol-based engineering team, and its Physical AI capabilities will be integrated into Bear Robotics, completing Bear's end-to-end Physical AI robotics platform. The transaction is expected to close in the coming days. Bear has built the world's most widely deployed fleet of service robots - more than 16,000 shipped into commercial service worldwide. Bear's robots already work together as one coordinated team through agentic multi-robot orchestration, moving freely through busy, changing spaces instead of following fixed tracks or routes. Most robotics compa
Ore Energy and Budget Thuis to Deploy 1 GWh of Multi-Day Iron-Air Energy Storage in a First for European Energy Suppliers22.6.2026 09:00:00 CEST | Press release
Dutch energy supplier commits to 1 GWh of iron-air energy storage to reduce consumer energy costs; First 400 MWh to be delivered in 2028 AMSTERDAM, NL / ACCESS Newswire / June 22, 2026 / Ore Energy, the Netherlands-based iron-air multi-day energy storage company, today announced an agreement with Budget Thuis, one of the largest Dutch energy suppliers, to deploy 1 GWh of iron-air long-duration energy storage (LDES). The agreement represents the largest iron-air energy storage offtake in continental Europe to date and the first with a European energy supplier. The agreement begins with a committed 400 MWh first phase planned for delivery in 2028. For Budget Thuis, the agreement is a strategic move to provide customers with more stable, affordable, and increasingly clean electricity as the Dutch power system becomes more dependent on wind energy. Ore Energy's multi-day storage technology is designed to store renewable electricity when it is abundant and dispatch it across extended low-re
Driving the World's Leading Supply Chains: 9 OMP Customers Named to The 2026 Gartner Top 2518.6.2026 15:00:00 CEST | Press release
As global leaders move from firefighting to foresight, OMP celebrates the enterprise visionaries scaling decision-driven intelligence at the speed of change. ANTWERPEN, BE / ACCESS Newswire / June 18, 2026 / OMP, a leading AI-powered provider of supply chain planning solutions, extends its congratulations to the 9 customer organizations recognized in the newly released Gartner® Supply Chain Top 25 and Masters for 2026. Now in its 22nd year, the Gartner Supply Chain Top 25 remains the definitive benchmark for supply chain excellence, evaluating global enterprises on financial performance, ESG initiatives, and community opinion. This year's rankings point to three capabilities separating market leaders: building an autonomous workforce where people and intelligent systems collaborate on decisions, adopting network-centric strategies that treat supply chain design as a continuous, adaptive process, and orchestrating decisions end-to-end across increasingly complex ecosystems. OMP's custom
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom